Publication:
Concomitant drug-and infection-induced antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with multispecific ANCA

dc.contributor.authorKontic, Milica (43761339600)
dc.contributor.authorRadovanovic, Sanja (56432618100)
dc.contributor.authorNikolic, Milos (56910382000)
dc.contributor.authorBonaci-Nikolic, Branka (10839652200)
dc.date.accessioned2025-06-12T21:57:34Z
dc.date.available2025-06-12T21:57:34Z
dc.date.issued2012
dc.description.abstractObjective: To report the first case of concomitant drug-and infection-induced antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) in a patient treated with propylthiouracil (PTU) and suffering from tuberculosis. Presentation and Intervention: A 28-year-old woman with PTU-treated hyperthyroidism presented with fever, purpura, pulmonary cavitations and ANCA to myeloperoxidase, bactericidal/permeability-increasing protein (BPI), proteinase-3 and elastase. Skin histopathology confirmed vasculitis. However, sputum examination revealed Mycobacterium tuberculosis. Remission was achieved after PTU withdrawal and treatment with antituberculosis drugs. Conclusion: Our case confirmed that BPI-ANCA are elevated in active tuberculosis. Multispecific ANCA were helpful for the diagnosis of concomitant PTU-and M. tuberculosis-induced AAV. Copyright © 2012 S. Karger AG, Basel.
dc.identifier.urihttps://doi.org/10.1159/000337944
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84865009842&doi=10.1159%2f000337944&partnerID=40&md5=611885312211ce00a717907646a2d91e
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/9620
dc.subjectAntineutrophil cytoplasmic autoantibodies
dc.subjectBactericidal/permeability-increasing protein
dc.subjectDrug-induced vasculitis
dc.subjectPropylthiouracil
dc.subjectTuberculosis
dc.titleConcomitant drug-and infection-induced antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with multispecific ANCA
dspace.entity.typePublication

Files